January 15, 2008 |
The heavily advertised drug Vytorin is no better than an inexpensive generic drug at blocking the damaging effects of high cholesterol levels, according to new data released by the drug's manufacturers Monday. In a study of 720 patients funded by the manufacturers, Vytorin -- a combination of the drugs simvastatin and ezetemibe -- reduced levels of LDLs, the so-called bad cholesterol, by about 29% more than simvastatin alone.
December 28, 2009 |
It seems like the pinnacle of medical science: For just a few hundred dollars, you can walk into just about any hospital in Southern California and ask a doctor to check your arteries for buildup of heart-attack-inducing calcium plaque. Most of the time, what goes on inside our bodies is a mystery, but there's something satisfying in the thought that a sophisticated piece of equipment can measure just how clogged our arteries really are (and how much more junk food we can afford, or not afford, to eat)
April 5, 2010 |
If you believe what you read in the cereal aisle, the right breakfast choice can lower your cholesterol — and cut your risk of heart disease. For the last few years, Cheerios boxes and ads have promoted the cereal's ability to help lower cholesterol; last year, for a time, ads promised the cereal could lower cholesterol by a very specific 4% in six weeks. (Cereal maker General Mills removed that particular claim from boxes after receiving a warning letter from the Food and Drug Administration in May stating that the claim had not been approved by the agency.
March 20, 1997 |
Figure skating star Scott Hamilton, a four-time world champion and the 1984 Olympic gold medalist, has been told he has testicular cancer, his public relations firm said Wednesday. The diagnosis was made by Eric Klein, a urologist, and Ronald Bukowski, an oncologist, of the Cleveland Clinic Foundation. Hamilton, 38, performed in Peoria, Ill., on Sunday night despite suffering from severe stomach pain during the last several weeks.
CALIFORNIA | LOCAL
July 31, 2000
Rene Favaloro, 77, Argentine surgeon who pioneered coronary bypass surgery. In 1967, Favaloro performed the first bypass operation on a 51-year-old woman at the Cleveland Clinic in Ohio, using a saphenous vein taken from the patient's leg to detour blood around blockages in her heart. The technique is now routinely performed on millions of people each year. Before Favaloro's breakthrough, coronary heart disease had been treated only with medication.
January 31, 1997 |
Ever since last summer, when a medical researcher reported that the zinc lozenge Cold-Eeze effectively reduces the severity and duration of colds, there's been a run on the remedy nationwide. Now it turns out the researcher, Dr. Michael Macknin of the Cleveland Clinic Foundation, knew he was onto a good thing: He purchased stock in the lozenge manufacturer, Quigley Corp. of Doylestown, Pa., before his favorable research was published in July.
April 19, 2012 |
A yearlong study of boxers' and mixed martial-arts fighters' brain activity has found those who fight for more than six years begin to experience damage and those who fight longer than 12 years expose themselves to an even greater decline each time they return to the ring. "What we've found suggests changes and damage in the brain happens years before symptoms emerge," said Dr. Charles Bernick, author of the study. "It's what we see in Alzheimer's and Parkinson's patients. " Bernick has supervised MRIs and computerized and cognitive tests of an estimated 170 fighters at the Cleveland Clinic's Las Vegas center in the past year.
January 10, 1998 |
A man who lost his voice in a motorcycle accident 19 years ago rasped "Hello" and "Hi, Mom" just a few days after what is believed to be the first larynx transplant since 1969. Timothy Heidler, 40, could be speaking in a normal voice in five months or less, doctors at the Cleveland Clinic said. In a 12-hour surgery on Sunday, Heidler received the larynx, part of the trachea and 70% of the throat of an unidentified donor.
November 30, 2006 |
Drug-coated stents raise the risk of potentially lethal blood clots in heart patients as much as fivefold compared with bare-metal devices, a Cleveland Clinic Foundation study has found. The researchers analyzed 14 studies involving 6,675 heart patients who received the two stent models sold in the U.S. Concerns about stent-related clotting first drew attention in September, when European doctors tied drug-coated stents to higher death rates.
CALIFORNIA | LOCAL
July 25, 1988 |
Oil from cold water fish, shown by several studies to help prevent heart attacks, may work its magic by retarding a growth protein that promotes clogged arteries, a Cleveland researcher says. Paul L. Fox of the Cleveland Clinic Research Institute said that test-tube experiments showed that oil extracted from the flesh of fish that live in cold water decreases levels of a protein called the platelet-derived growth factor.